polyadenylation [poly(A)] site from the insulin gene was substituted for the 3' long terminal repeat (LTR) at the end of the nef reading frame (I 1) . This design eliminated cis-acting sequences crucial for packaging, reverse transcription, and integration of transcripts derived from the packaging plasmid (12) . To broaden the tropism of the vector, we used a second plasmid that encodes a heterologous envelope protein for pseudotyping the particles generated by pCMVAR9 (13) . Two variants of this construct were used: One variant encodes the amphotropic envelope of MLV (Ampho), and the other encodes the G glycoprotein of vesicular stomatitis virus (VSV G) (14) . The latter envelope offers the additional advantage of high stability, which allows for HIV provirus FT?UlI Gaq particle concentration by ultracentrifugation (15) . The (16) . This design had a dual purpose: first, to increase packaging efficiency, as both gag and env RNA determinants have been demonstrated to enhance this process (17) , and second, to allow the efficient transcription and cytoplasmic export of full-length vector transcripts only in the presence of the HIV Tat and Rev regulatory proteins, both of which are encoded by the packaging plasmid, pCMVAR9. In the absence of these transacting factors, the only detectable expression originated from the internal promoter in the vector (18) . The Escherichia coli ,-galactosidase (P-gal) or the firefly luciferase coding sequences were inserted into pHR' downstream of the hCMV immediate early promoter to serve as reporter genes.
Replication-defective retroviral particles were generated by transient cotransfection of 293T human kidney cells with the three-plasmid combination (19) . MLV-derived (17, 22) . Potentially contributing to this increased efficiency is the incorporation of accessory HIV-1 genes into the packaging construct, including nef that markedly en- (33) . Significant levels of luciferase activity were detected in an envelope-dependent manner (Table 2 ). In contrast, only background levels of luciferase activity were measured in macrophages inoculated with a comparable VSV G-pseudotyped MLV-based vector (34) . To rule out that the HIV vector was infecting a small proportion of macrophages that were proliferating, we generated mutant packaging constructs where Vpr and the nuclear localization signal (NLS) present in the MA protein were inactivated (35) . At least one of these two elements is essential for viral infection in macrophages, because they mediate nuclear import of the HIV preintegration complex (7) (8) (9) . A vector assembled from a mutant packaging construct in which both Vpr and the MA NLS are inactivated was severely reduced in its ability to transduce macrophages ( (18) . The expression of ,B-gal in neurons in the striatum and the hippocampus could be detected after a 30-day period, the longest time tested (Fig. 3 , bottom two panels). (38) . Furthermore, the vectors described here are replication defective; consequently, the transduced cells lack viral protein that could trigger a cellular immune response. A major goal of our work was to establish a proof of principle that lentiviral vectors can be used for stable in vivo gene delivery in nondividing cells. For human experimentation, it may be more prudent to develop vectors derived from nonhuman lentiviruses such as simian immunodeficiency virus, bovine immunodeficiency virus, or equine infectious anemia virus. We believe that the generation of safe and efficacious lentiviral vectors will significantly advance the prospects of human gene therapy. (1996) . 28. Mutant packaging plasmids were constructed by substituting in pCMVAR9 a Bcl I-Sal cassette containing the mutations from plasmids pAINR8 (9) and pHIV-Hygro-D64V (27). Although residual transducing activity was scored for the vector assembled from the packaging plasmid carrying the D64V integrase mutation, p-gal-positive cells showed on average significantly weaker staining than those transduced by the wild-type vector and were apparently unable to form foci of stably transduced cells. This is also consistent with the residual activity observed for the D64V integrase mutation in the context of the HIV-1 genome (27) 
